BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gougeon ML, Poirier-Beaudouin B, Ausseil J, Zérah M, Artaud C, Heard JM, Deiva K, Tardieu M. Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome. Front Immunol 2021;12:655478. [PMID: 34040605 DOI: 10.3389/fimmu.2021.655478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Pardridge WM. A Historical Review of Brain Drug Delivery. Pharmaceutics 2022;14:1283. [PMID: 35745855 DOI: 10.3390/pharmaceutics14061283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
2 Pardridge WM. Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins. Adv Drug Deliv Rev 2022;184:114234. [PMID: 35307484 DOI: 10.1016/j.addr.2022.114234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Benatti HR, Gray-Edwards HL. Adeno-Associated Virus Delivery Limitations for Neurological Indications. Hum Gene Ther 2022;33:1-7. [PMID: 35049369 DOI: 10.1089/hum.2022.29196.hrb] [Reference Citation Analysis]
4 Deiva K, Ausseil J, de Bournonville S, Zérah M, Husson B, Gougeon ML, Poirier-Beaudouin B, Zafeiriou D, Parenti G, Heard JM, Tardieu M. Intracerebral Gene Therapy in Four Children with Sanfilippo B Syndrome: 5.5-Year Follow-Up Results. Hum Gene Ther 2021;32:1251-9. [PMID: 34405688 DOI: 10.1089/hum.2021.135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]